1-5 of 5
Shalin K. Kothari, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Weekly Dosing Schedule of Brentuximab Vedotin in Mycosis Fungoides/Sezary Syndrome and Aggressive T Cell Lymphomas

Megan Lee, BS, Molly Schiffer, PharmD, Iris Isufi, MD, Scott F. Huntington, MD MPH, Mina L. Xu, MD, Stuart Seropian, MD, Lohith Gowda, MD, Shalin K. Kothari, MD, Michael Girardi, MD PhD, Francine M. Foss, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 21–22.
https://doi.org/10.1182/blood-2020-139790
Published: 2020
Journal Articles

A Once Daily, Oral, Triple Combination of BTK Inhibitor, mTOR Inhibitor and IMiD for Treatment of Relapsed/Refractory Richter's Transformation and De Novo Diffuse Large B-Cell Lymphoma

Anthony R. Mato, MD, Stephen J. Schuster, MD, Francine M. Foss, MD, Iris Isufi, MD, Shalin K. Kothari, MD, Wei Ding, MD PhD, Danielle M. Brander, MD, Andrea Sitlinger, MD, Allison C. Rosenthal, D.O., Jose F. Leis, MD PhD, Han W. Tun, MD, Kaitlin Kennard, RN, BSN, Allison R. Nelson, RN, Victoria Falco, BSN, Celina J. Komari, BS, Amber B. Koehler, PA-C, MS, Rachel Stowe, RN, Wei He, PhD, Albert Kearney, PhD, Min Gui, PhD, Tim McKinlay, Lindsey E Roeker, MD, Meghan C. Thompson, MD, Scott F. Huntington, MD MPH
Journal: Blood
Blood (2020) 136 (Supplement 1): 21–22.
https://doi.org/10.1182/blood-2020-138896
Published: 2020
Journal Articles

Impact of Novel Agents on Outcomes of Patients with Classical Hodgkin Lymphoma and Primary Treatment Failure

Narendranath Epperla, MDMS, Luciano J. Costa, MD PhD, John L Vaughn, MD, Walter Hanel, MD PhD, Saba Raya, MD, Amanda F Cashen, MD, Rehan Sarmad, MD MBBS, Talha Badar, MD, Mehdi Hamadani, MD, Yang Liu, MD, Stefan K. Barta, MD MRCP, MS, Paolo Caimi, MD, Tarsheen K. Sethi, MD, Nishitha Reddy, MD, Madelyn Burkart, MD, Reem Karmali, MD, Celeste Bello, MD, Julio C. Chavez, MD, Shalin K. Kothari, MD, Francisco J. Hernandez-Ilizaliturri, MD, Hatcher J. Ballard, BS, Jakub Svoboda, MD, Lukas Emery, DO, Frederick Lansigan, MD, Martha Glenn, MD, Michael C. Churnetski, Jonathon B. Cohen, MDMS, Caryn Sorge, MD, Ana C. Xavier, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1554.
https://doi.org/10.1182/blood-2019-129199
Published: 2019
Journal Articles

Effects of Proteasome Inhibition in the Anti-Tumor Activity of Venetoclax in Mantle Cell Lymphoma Pre-Clinical Models

Shalin K. Kothari, MD, Cory Mavis, BSc, MSc, Juan Gu, MD PhD, Francisco J. Hernandez-Ilizaliturri, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2942.
https://doi.org/10.1182/blood-2018-99-116510
Published: 2018
Journal Articles

Outcomes of Patients with Limited-Stage Aggressive Large B-Cell Lymphoma with MYC Rearrangement with and without BCL2 and/or BCL6 Rearrangements: A Retrospective Analysis from 15 US Academic Centers

Shalin K. Kothari, MD, Shaoying Li, MD, L. Jeffrey Medeiros, MD, Emily C. Ayers, MD, Daniel J. Landsburg, MD, David A. Bond, MD, Kami J. Maddocks, MD, Anshu Giri, MD, Brian T. Hess, MD, Luu Q. Pham, Ranjana Advani, MD, Yang Liu, MD, Stefan Klaus Barta, MDMRCP,MS, Julie M. Vose, MDMBA, Michael C. Churnetski, BS, Jonathon B. Cohen, MDMS, Madelyn Burkart, MD, Reem Karmali, MD, Joanna Zurko, MD, Amitkumar Mehta, MD, Adam J Olszewski, MD, Sarah S Lee, MD, Brian T. Hill, MD PhD, Timothy F. Burns, MD, Frederick Lansigan, MD, Emma Rabinovich, MD, David Peace, MD, Adrienne Groman, MS, Kris Attwood, PhD MS, Francisco J. Hernandez-Ilizaliturri, MD, Pallawi Torka, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 451.
https://doi.org/10.1182/blood-2018-99-111530
Published: 2018